Sunday, June 7, 2026
ADVT 
National

Canadian data: risk of death higher with Delta

Darpan News Desk The Canadian Press, 05 Oct, 2021 10:19 AM
  • Canadian data: risk of death higher with Delta

A new study using Canadian data suggests the Delta variant of the COVID-19 virus causes more serious disease and is associated with an increased risk of death compared to previous strains — dangers that are drastically reduced with vaccination.

The study, conducted by researchers at the University of Toronto and published Tuesday in the Canadian Medical Association Journal, analyzed more than 212,000 cases of COVID-19 reported in Ontario between Feb. 7 and June 27, 2021.

They found that those infected with the Alpha variant, which drove the province's third wave in the early spring, or the Beta or Gamma variants were 52 per cent more likely to be hospitalized, 89 per cent more likely to need intensive care and 51 per cent more likely to die of the infection than those who caught the early 2020 version of the virus.

Among Delta cases, they found a 108 per cent increased risk for hospitalization, 235 per cent increased risk for ICU admission and 133 per cent increased risk for death compared to the original virus strain.

Some of the findings echo results from previous research papers published across the globe, but co-author David Fisman believes the study is the first large-scale analysis to include Canadian data.

The U of T epidemiology professor said that could be an important factor for some to more strongly consider the risk that Delta carries and get vaccinated.

"(The finding) jives with what the intensivists are telling us, which is that people come into hospital much sicker now than they did a year ago, but to see it in the numbers was initially pretty startling," Fisman said.

"I hope by seeing that this really is a more dangerous virus than it was a year ago, maybe that will motivate some folks who are holding out in terms of vaccination."

The study found people infected with variants of concern were significantly younger and less likely to have comorbidities than those with non-variant infections, while the increased risk of adverse outcomes persisted even after researchers adjusted for age, sex, comorbidities and other factors.

But researchers also looked at vaccine effectiveness, which blunted the severity of the variants by reducing risk of severe disease and death in partially and fully vaccinated people.

Fisman said one of the main reasons Delta didn't devastate its way through Canada the same way it did in India was because the variant emerged here just as vaccination was ramping up.

Still, Fisman said Delta presents huge risk, especially for the unvaccinated who now make up the vast majority of COVID-19 cases, hospitalizations and deaths in Canada and elsewhere. Just over 80 per cent of those eligible were fully vaccinated as of Sept. 25, according to Health Canada.

Fisman said Thanksgiving gatherings can be risky if they involve mingling of vaccinated and unvaccinated adults, but danger can be mitigated by eating dinner outdoors if weather permits, keeping windows open or using air filtration systems as "your next line of defence."

"Non-vaccinated adults are potentially creating risk for those around them," he said. "We're sort of expecting to see a bit of a bump in case numbers after Thanksgiving, so it'll be interesting to see whether or not that pans out."

Nearly 77 per cent of the cases analyzed in the study, which ended before Delta firmly took hold on Ontario's caseload, were infected with Alpha, Beta or Gamma variants while 2.8 per cent were classified as "probable Delta infections." Roughly 22 per cent were infected with non-variants.

Fisman and his team found the Delta variant was present in Ontario by April 2021 and became the dominant strain by July.

Fisman said he wasn't surprised by how quickly Delta overtook other variants, which have "mostly disappeared" in the province.

"It's just basically natural selection sped up," he said. "We know that Alpha, Beta, Gamma, those were about one-and-a-half times as infectious as the Wuhan variant COVID, and then Delta approximately doubled that yet again.

"It's a much more infectious strain and you see it sort of displacing those earlier variants."

MORE National ARTICLES

Pipeline politics back before Commons committee

Pipeline politics back before Commons committee
Michigan has refused to concede that the state's own experts have concluded there are no clear alternatives to the pipeline, he wrote to the governor in a letter earlier this year.

Pipeline politics back before Commons committee

Minister defends attack petition on Bigfoot movie

Minister defends attack petition on Bigfoot movie
Sonya Savage also says it’s critical to push back constantly against any false narrative that casts Alberta’s wellspring industry in a negative light.

Minister defends attack petition on Bigfoot movie

Surrey Vaisakhi parade cancelled for 2021 due to COVID19

Surrey Vaisakhi parade cancelled for 2021 due to COVID19
The event was to take place in Surrey on April 24th. The Surrey Vaisakhi parade is the largest in Canada and outside of India drawing crowds in excess of over half a million. 

Surrey Vaisakhi parade cancelled for 2021 due to COVID19

Wanted: Ideas to prepare for next major calamity

Wanted: Ideas to prepare for next major calamity
The notice says these fall somewhere between relatively common events such as seasonal floods and highly improbably risks such as an asteroid hitting Earth.

Wanted: Ideas to prepare for next major calamity

O'Toole says he wouldn't cut foreign aid

O'Toole says he wouldn't cut foreign aid
O'Toole says a Conservative government also wouldn't cut aid funding, but would place a greater focus on measuring outcomes associated with that money.

O'Toole says he wouldn't cut foreign aid

AstraZeneca vaccine OK for seniors: NACI

AstraZeneca vaccine OK for seniors: NACI
The decision reverses a recommendation made by the body two weeks ago when the panel of vaccine experts said AstraZeneca hadn't included enough people over the age of 65 in its clinical trials.

AstraZeneca vaccine OK for seniors: NACI